the present invention relates to new stable enteric coated pharmaceutical dosage forms for oral use containing omeprazole or lansoprazole , to a formulation and a method for the manufacture of such a dosage forms , and to a method of gastric acid pump inhibition and providing gastrointestinal cytoprotective benefit by using them .